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et al., 2002). This discrepancy may
have several causes, such as the study
design (family-based vs. population-
based), ethnic background, inaccurate
reporting because of self-reported data,
or the lower statistical power of our
study (66%, input values were derived
from Gudjonsson et al. (2002); signifi-
cance level 0.05, OR 2.3, allele fre-
quency 0.28, dominant model).
Our results suggest that the Koebner
phenomenon in psoriasis is unlikely to
be dependent on the LCE3B/C geno-
type. Therefore, the biological role of
LCE3B and LCE3C deletion in develop-
ment and/or maintenance of psoriasis
remains to be explained.
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TO THE EDITOR
Ceramide is a family of lipid molecules
composed of a sphingoid base and
a fatty acid (FA) (Masukawa et al.,
2008). Ceramide constitutes a major
lipid component of cutaneous perme-
ability barrier, accounting forB50% of
the epidermal membrane structure
(Mizutani et al., 2009). Accordingly,
the alteration of ceramide in the derma-
toses with barrier dysfunction has
been a subject of intensive research
Table 1. No association between LCE3B/C copy number and
koebnerization in psoriasis patients
LCE3B/C
copy number Genotype
Koebner
positive
Koebner
negative P
OR
(95% CI)
0 del/del 20 (43%) 66 (45%) 0.835 1.06 (0.64–1.74)
1 del/wt 21 (46%) 65 (45%)
2 wt/wt 5 (11%) 15 (10%)
Abbreviations: CI, confidence interval; del, deletion; OR, odds ratio; wt, wild type.
Abbreviations: AD, atopic dermatitis; CBF, cutaneous barrier function; FA, fatty acid; OXZ, 4-ethoxy-
methylene-2-phenyl-2-oxazolin-5-one; SC, stratum corneum; TEWL, trans-epidermal water loss
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(Imokawa et al., 1991). Recently,
Ishikawa et al. (2010) and we (Joo
et al., 2010) demonstrated that the
profiles of FA lengths of ceramides in
the stratum corneum (SC) of atopic
dermatitis (AD) patients or people with
low cutaneous barrier function (CBF)
are different from those with normal
CBF. Especially, the ceramides with
very long-chain FAs are markedly
depleted in SC with impaired CBF
and the average chain length of FAs
of ceramides is negatively correlated
with trans-epidermal water loss (TEWL)
in AD patients (coefficient, 0.853,
Po0.001) (Ishikawa et al., 2010), sug-
gesting that synthesis of the FA moiety
of ceramides may be dysregulated in
AD. Here, we tried to elucidate the
mechanism underlying the depletion
of ceramides with very long-chain FAs
in the SC of AD, by using a hapten-
induced AD model in mice.
All animal experiment procedures
were approved by the AmorePacific
Institutional Animal Care and Use
Committee. AD-like skin lesions were
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Figure 1. Impaired barrier functions and changes in ceramide species in atopic dermatitis (AD)-like skin lesion. (a) Appearance (upper), histology of skin
(middle), and microscopic images of stratum corneum (SC) samples obtained with D-squame tapes (Cuderm, Dallas, TX, diameter, 2.2 cm, lower). Bar¼100 mm.
(b) The severity of AD-like symptoms was evaluated by the sum of the individual scores (0, none; 1, mild; 2, moderate; 3, severe) on dryness, excoriation,
erythema, and edema. (c) Skin thickness measured as skin-fold thickness with micrometer (Mitutoyo, Kawasaki, Japan). (d) Trans-epidermal water loss (TEWL)
measured on the back with Vapometer (Delfin Technology, Kuopio, Finland). (e) Ceramide species were quantified in SC samples collected using five
consecutive D-squame tapes from each animal. Tapes were cut into two equal parts and each half was used for lipid extraction and protein assay. Ceramide
species were identified by examining fragmentation patterns in liquid chromatography–mass spectrometry (Waters Alliance/Q-Premier XE, Manchester, UK)
and comparing with those of commercial standards (C16Cer, C18Cer, C20Cer and C24Cer, Avanti Polar Lipids, Alabaster, AL). Values are expressed as the
means±SE of 5–8 animals per group. *Student’s t-test between control (CTRL) and 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (OXZ)-treated mice (Po0.05).
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induced in female hairless mice with
repeated topical applications of 4-
ethoxymethylene-2-phenyl-2-oxazolin-
5-one (OXZ, Sigma-Aldrich, St Louis,
MO; on day 0 with 50 ml of 5% to the
cervical area and from day 1 to 15 with
100ml of 0.1% on bilateral flanks daily).
Along with the development of typical
AD-like symptoms, including the typi-
cal clinical signs of dermatitis (Matsuda
et al., 1997), skin thickening, inflam-
matory cell infiltrations, and epidermal
scaling (Figure 1a–c), the impairment of
CBF was well simulated as determined
by significantly increased TEWL in
OXZ-treated mice (Figure 1d). The com-
position of ceramide[NS] (non-hydroxy
acyl sphingosine-type ceramide) (Motta
et al., 1993) was quantified as a repre-
sentative ceramide class in SC samples
of control and OXZ-treated mice
with a sensitive LC/MS/MS-ESI tech-
nique (Joo et al., 2010) to examine the
alteration of FA lengths of ceramides.
As observed in AD patients (Ishikawa
et al., 2010), the ceramide[NS] with
very long-chain FAs (XC24) was mark-
edly reduced in AD-like skin lesions,
whereas those with shorter-chain FAs
(pC22) were higher in AD-like skin
lesions compared with normal skin
(Figure 1e).
To further elucidate a correlation
between the respective ceramide[NS]
species and their association with
AD, principal component analysis, a
multivariate analysis that can exam-
ine the inter-relationship of multiple
factors in an unsupervised manner,
was conducted with individual levels
of ceramide[NS] species. Remarkably,
the principal component 2 (PC2, y-axis)
could clearly differentiate the control
mice from those treated with OXZ
(Figure 2a). Plotting of the loadings of
PC2 for the respective ceramide[NS]
species showed the apparent separation
of ceramide[NS] species with shorter
carbon-chain FAs (pC22) from those
with very long-chain FAs (XC24)
(Figure 2b), reflecting that FA chain
lengths of ceramide species may be
affected by AD. Ceramides are synthe-
sized by ceramide synthases from a
sphingosine base and a fatty acyl-CoA
(Mizutani et al., 2009). Fatty acyl-CoAs
with carbon chains up to C16 are
synthesized by FA synthase complex
in mammals, but for the generation
of longer FAs (XC18) membrane-asso-
ciated FA elongases are required
(Jakobsson et al., 2006). At least seven
mammalian ELOVL (enzymes for elon-
gation of very long-chain FAs) subtypes
(ELOVL1–7) have been identified
(Matsuzaka et al., 2002) and skin
expresses ELOVL1, ELOVL3, ELOVL4,
and ELOVL6, with ELOVL3 limited to
the hair follicles and sebaceous glands
(Guillou et al., 2010). To investigate the
involvement of elongases in the altera-
tion of ceramide[NS] species in AD-like
skin lesions, we examined the expres-
sion of Elovl1, Elovl4, and Elovl6 in skin
tissues using RT–PCR. Remarkably,
Elovl1, Elovl4, and Elovl6 were down-
regulated in OXZ-treated mice and
Elovl6 was the least affected (Figure
2c). In line with this, western blot
analysis showed that enzyme levels of
Elovl1 and Elovl4 were lower in OXZ-
treated mice (Figure 2d). ELOVL1 and
4 are the essential elongases for the
production of very long-chain FAs
(XC24), while ELOVL6 is for medium-
chain FAs (C18-C22) from C16 FA
(Soupene and Kuypers, 2008). Reduced
expression of Elovl1 and Elovl4 impairs
the elongation of FA beyond C22 and
subsequently results in the accumu-
lation of precursor medium-chain
FAs (pC22) (Ofman et al., 2010). Mice
lacking a functional copy of Elovl4
are unable to produce an adequate
amount of longer FAs (XC26) and,
notably, fail to develop a functionally
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Figure 2. Principal component analysis of ceramide species and the expression of elongases in AD-like skin lesion. (a) Principal component analysis was
conducted with the respective contents of ceramide species in individual animals using Minitab statistical software (State College, PA) and a score plot was
drawn with PC1 and PC2. The open circles represent five control animals (CTRL) and the filled circles denote five animals treated with 4-ethoxymethylene-2-
phenyl-2-oxazolin-5-one (OXZ). (b) The plot of the coefficients of the respective ceramide species for PC2. (c) Dorsal skin biopsy samples were taken and
stored in RNAlater RNA stabilization reagent (Qiagen, Germantown, MD) at 80 1C. Total RNA was purified from biopsy samples (6 mm f) using RNeasy
Plus Mini kit (Qiagen). Complementary DNA of Elovl1, 4, 6, and GAPDH was synthesized by RT–PCR and quantitative PCR was performed using
SYBR Safe DNA gel stain (Invitrogen, Carlsbad, CA). (d) Western blot analysis of Elovl1 and 4 in the biopsied skin tissues.
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competent cutaneous permeability bar-
rier (Cameron et al., 2007). In this
regard, decreased expression of elon-
gases in AD-like skin lesions and
subsequent failure to adequately pro-
duce long FAs might have contributed
to the depletion of the ceramide[NS]
species with very long-chain FAs that
are more essential to CBF than those
with shorter FAs (Janusova et al., 2011).
Interestingly, peroxisome proliferator
activator receptors, liver X receptor,
and the sterol regulatory element bind-
ing protein signaling pathways, which
are important in the transcriptional
regulation of elongases, also have
critical roles in epidermal barrier func-
tion (Elias, 2005), which may be in line
with the alteration of elongase and
disrupted CBF in AD-like skin lesions.
In conclusion, we found that the
profiles of FA lengths of ceramide
species are different in AD-like skin
lesions, i.e., the ceramides with very
long FAs (XC24) decreased whereas
those with shorter FAs (pC22) in-
creased in AD-like skin lesions. The
expression levels of elongases were
downregulated in AD-like skin lesions,
which might have impaired the synth-
esis of ceramide species with very
long FAs and tilted the balance toward
the dominance of ceramide species
with shorter FAs over those with longer
FAs in the SC of AD. These results
suggest that the alteration in elongases
as well as in the profile of FA lengths
of ceramides could be useful for the
diagnosis of AD. More importantly,
the modulation of elongases might
be effective in repairing damaged CBF
in AD.
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Exposure to Phlebotomus papatasi and/or Leishmania
major: Possible Etiologic Link to Tunisian Pemphigus
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TO THE EDITOR
Epidemiological data in Brazil indi-
cated a significant association between
pemphigus and a frequent exposure
to black flies (Lombardi et al., 1992;
Aoki et al., 2004). Accordingly, recent
records demonstrated that anti-desmo-
glein 1 (Dsg1) antibodies are present in
endemic areas of Brazilian pemphigus
foliaceus, not only in pemphigus sub-
jects but also in patients with parasitic
diseases transmitted by hematophagous
vectors (onchocerciasis: 83%, Chagas
disease: 58%, and leishmaniasis:
43%) (Diaz et al., 2004). Diaz et al.
(2004) suggested that saliva of the
Abbreviations: BP, bullous pemphigoid; Dsg1, desmoglein; HC, healthy control; L. major, Leishmania
major; P. papatasi, Phlebotomus papatasi; SGE, salivary gland extract; ZCL, zoonotic cutaneous
leishmaniasis
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